Confocal Microscopy and Lacrimal Gland in Sjogren's Syndrome
The Application of In Vivo Confocal Scanning Laser Microscopy in the Evaluation of the Secretory Glands in Patients With Sjögren's Syndrome
1 other identifier
observational
30
1 country
1
Brief Summary
Traditional methodological clinical and instrumental diagnostics of the lacrimal gland for the study of glandular architecture and functions are limited and include analysis of tear constituents, evaluation of apparent diffusion coefficients in magnetic resonance imaging and histopathological evaluation of lacrimal gland biopsy specimens. Confocal microscopy is a new emerging technology which is useful as a supplementary diagnostic tool for in vivo assessment of anterior-segment disorders.The use of in vivo confocal microscopy in a comparative study of the microscopic morphology of the salivary/lacrimal glands have not been reported up to date. In this study, we employ laser scanning confocal microscopy to evaluate the morphological changes of the salivary/lacrimal glands in patients with primary Sjögren's syndrome and compare the results with those of healthy control subjects.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 12, 2009
CompletedFirst Posted
Study publicly available on registry
June 15, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2010
CompletedJune 15, 2009
June 1, 2009
3.2 years
June 12, 2009
June 12, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Inflammatory cell density
1.5 years
Study Arms (2)
Dry eye group
Dry eye patients with Primary Sjogren's syndrome
Controls
Healthy subjects without dry eyes
Eligibility Criteria
Patients with primary SS and healthy controls
You may qualify if:
- The Sjögren's syndrome diagnosis was made according to the revised American-European consensus criteria.
- Briefly, the patients had to have ocular and oral symptoms of dryness,
- clinically diagnosed dry eye and dry mouth disease,
- serum rheumatoid factor and antinuclear antibody levels ≥1:160,
- positive serology for anti SS-A or anti SS-B antibodies,
- labial salivary gland inflammatory infiltration focus score ≥2 and consents for lacrimal gland biopsy to be included into this study.
You may not qualify if:
- Patients with any history of ocular surgery including punctal occlusion,
- other ocular or systemic disease
- or a history of topical/ systemic drug use or contact lens wear or
- other systemic disorders that would cause dry eyes or that would alter the ocular surface.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Keio Universitylead
Study Sites (1)
Keio University School of Medicine
Tokyo, 1608582, Japan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Kazuo Tsubota, Professor
Keio University
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 12, 2009
First Posted
June 15, 2009
Study Start
October 1, 2007
Primary Completion
December 1, 2010
Last Updated
June 15, 2009
Record last verified: 2009-06